Search

Novartis AG

Cerrado

152.9 -1.75

Resumen

Variación precio

24h

Actual

Mínimo

154.74

Máximo

157.3

Métricas clave

By Trading Economics

Ingresos

110M

3.3B

Ventas

894M

14B

P/B

Media del Sector

23.213

68.51

BPA

2.41

Rentabilidad por dividendo

3.04

Margen de beneficios

22.654

Empleados

75,267

EBITDA

526M

5.9B

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 Meses

+1.41% upside

Dividendos

By Acuity

Rentabilidad por dividendo

Media del Sector

3.04%

2.29%

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

6.7B

292B

Apertura anterior

154.65

Cierre anterior

152.9

Novartis AG Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

10 ago 2026, 23:56 UTC

RingCentral Inc. shares advanced in after-market trading, continuing a month-long upward trend and remaining significantly above the 20-day moving average.

10 ago 2026, 23:56 UTC

Aramark shares are higher in after-market trading, recovering from an early decline. The stock remains below its 20-day moving average.

10 ago 2026, 23:56 UTC

Vir Biotechnology Inc. shares advanced in after-market trading, reflecting a modest increase from Monday's close, though still below the 20-day moving average.

10 ago 2026, 23:56 UTC

CF Industries Holdings Inc shares are lower in after-market hours, with no specific news identified to explain the decline. The stock is below its 20-day moving average.

10 ago 2026, 23:56 UTC

Yelp Inc. shares rose slightly in after-market trading, despite being below the 20-day moving average and near the lower end of their one-month range.

10 ago 2026, 23:56 UTC

NN Inc shares are higher in after-market trading, maintaining a position above their 20-day moving average and near the upper end of their one-month range.

10 ago 2026, 23:56 UTC

Johnson Controls International PLC shares are higher in after-market trading, reflecting a modest uptick following Monday's close. The stock remains above its 20-day moving average.

10 ago 2026, 23:56 UTC

B&G Foods Inc. shares are lower in after-market trading, reflecting broader market declines and cautious sentiment following recent labor market data.

10 ago 2026, 23:56 UTC

Dynatrace Inc shares are higher in after-market trading, despite no specific news. Broader market sentiment is influenced by recent economic data.

10 ago 2026, 23:56 UTC

New Fortress Energy shares are higher in after-market trading, reaching 2.94% above Monday's close, significantly above the 20-day moving average.

10 ago 2026, 23:56 UTC

Social Media

NetApp Inc shares are trading higher in after-market hours following an upgrade from Morgan Stanley, driven by increased demand for storage solutions.

10 ago 2026, 23:56 UTC

Ardelyx Inc shares are higher in after-market trading, despite no specific news driving the move. Recent market conditions include cautious optimism following a jobs report.

10 ago 2026, 23:56 UTC

News

Iovance Biotherapeutics reported second-quarter revenue of $99.3 million, a 66% increase, contributing to a rise in shares during after-market hours.

10 ago 2026, 23:56 UTC

Target Corp shares declined in after-market trading, reflecting a directional move since Monday's close. The stock remains above its 20-day moving average.

10 ago 2026, 23:56 UTC

Correlated Moves

Host Hotels & Resorts Inc. is trading lower in after-market hours, reflecting broader declines in small-cap stocks and cautious market sentiment following a recent jobs report.

10 ago 2026, 23:56 UTC

Correlated Moves
ETF Constituents

Financial Select Sector SPDR Fund declines in after-market trading as top holdings Visa, FIS, and PayPal post losses amid flat U.S. markets.

10 ago 2026, 23:56 UTC

Enovix Corp shares are higher in after-market trading, showing strength above their 20-day moving average amid cautious market optimism following recent labor data.

10 ago 2026, 23:56 UTC

Correlated Moves

indie Semiconductor Inc's shares are lower in after-market hours, influenced by broader market caution and a decline in the Russell 2000 Index.

10 ago 2026, 23:56 UTC

Hawaiian Electric Industries shares are lower in after-market hours, with no specific news identified. The stock remains below its 20-day moving average.

10 ago 2026, 23:56 UTC

Quantumscape Corp shares traded lower in after-market hours, with no specific news identified. The stock remains above its 20-day moving average.

10 ago 2026, 23:56 UTC

Tower Semiconductor shares are higher in after-market hours, with no specific news identified. The stock remains well above its 20-day moving average.

10 ago 2026, 23:56 UTC

Correlated Moves

US 5Y Treasury Bond Index trades roughly flat as traders reassess September rate hike odds after a jobs report showed a decline of 23,000 jobs.

10 ago 2026, 23:56 UTC

Correlated Moves

US 10Y Treasury Bond Index trades near unchanged as traders reassess September rate hike odds following a jobs report indicating a decline of 23,000 jobs.

10 ago 2026, 23:52 UTC

Sarepta Therapeutics shares are lower in after-market hours, with no specific news identified for the decline amid broader market sentiment influenced by labor report data.

10 ago 2026, 23:52 UTC

Correlated Moves
ETF Constituents
Macro News
Social Media

Energy Select Sector SPDR Fund lower in after-market hours despite crude oil prices rising to $82.25 amid concerns over the Strait of Hormuz reopening.

10 ago 2026, 23:52 UTC

Event
News
Social Media

Plug Power shares are higher in after-market trading following strong second-quarter results that exceeded analyst expectations and an improved revenue growth outlook.

10 ago 2026, 23:51 UTC

Modine Manufacturing Co shares are higher in after-market trading, buoyed by last Friday's labor report that reduced expectations for Federal Reserve rate hikes.

10 ago 2026, 23:51 UTC

Correlated Moves

Stanley Black & Decker Inc shares declined in after-market trading amid weak market performance and downward pressure from recent labor market data.

10 ago 2026, 23:51 UTC

Shoals Technologies Group Inc shares are lower in after-market trading. Broader market sentiment is affected by a recent labor report and Fed rate hike expectations.

10 ago 2026, 23:51 UTC

Hilltop Holdings Inc is trading lower in after-market hours, continuing a decline since Monday's close amid broader market sentiment influenced by a weak labor report.

Comparación entre iguales

Cambio de precio

Novartis AG previsión

Precio Objetivo

By TipRanks

1.41% repunte

Estimación a 12 Meses

Media 159 USD  1.41%

Máximo 180 USD

Mínimo 139 USD

De acuerdo con 5 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Novartis AG Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

5 ratings

2

Comprar

2

Mantener

1

Vender

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Novartis AG

Novartis AG engages in the research, development, manufacture, and marketing of healthcare products in Switzerland and internationally. The company offers prescription medicines for patients and physicians. The company also provides Pluvicto, lutetium Lu 177 vipivotide tetraxetan, indicated for the treatment of adult patients with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer; and Lutathera, lutetium Lu 177 dotatate, a prescription medicine used to treat adults and children aged 12 years and older with gastroenteropancreatic neuroendocrine tumors. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology. The company has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol; and Dawn Health for the development and commercialization of Ekiva, a digital solution designed for people living with Paroxysmal Nocturnal Hemoglobinuria. It also has a research collaboration and license agreement with Schrödinger, Inc. to identify and develop various therapeutic candidates; and a strategic collaboration with Vyriad, Inc. for the discovery and development for vivo chimeric antigen receptor T-cell therapies. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.
help-icon Live chat